Bis(N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5,5-difluoro-4-methylpiperidin-3-yl]methyl]methanesulfonamide);1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidine-3-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]-1,1,1-trifluoromethanesulfonamide;6-(difluoromethyl)-3-[6-[2-(trifluoromethyl)piperidin-1-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine
C90H92F20N34O7S3 — CID 159829288
Data last refreshed: (MolForge compound catalog, from PubChem)
About Bis(N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5,5-difluoro-4-methylpiperidin-3-yl]methyl]methanesulfonamide);1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidine-3-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]-1,1,1-trifluoromethanesulfonamide;6-(difluoromethyl)-3-[6-[2-(trifluoromethyl)piperidin-1-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine
Bis(N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5,5-difluoro-4-methylpiperidin-3-yl]methyl]methanesulfonamide);1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidine-3-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]-1,1,1-trifluoromethanesulfonamide;6-(difluoromethyl)-3-[6-[2-(trifluoromethyl)piperidin-1-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine (PubChem CID 159829288) has the molecular formula C90H92F20N34O7S3 and a molecular weight of 2238.12 g/mol. Its IUPAC name is bis(N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5,5-difluoro-4-methylpiperidin-3-yl]methyl]methanesulfonamide);1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidine-3-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]-1,1,1-trifluoromethanesulfonamide;6-(difluoromethyl)-3-[6-[2-(trifluoromethyl)piperidin-1-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine.
Molecular Properties
| Compound Name | Bis(N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5,5-difluoro-4-methylpiperidin-3-yl]methyl]methanesulfonamide);1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidine-3-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]-1,1,1-trifluoromethanesulfonamide;6-(difluoromethyl)-3-[6-[2-(trifluoromethyl)piperidin-1-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine |
|---|---|
| PubChem CID | 159829288 |
| Molecular Formula | C90H92F20N34O7S3 |
| Molecular Weight | 2238.12 g/mol |
| Exact Mass | 2236.67 |
| IUPAC Name | bis(N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]-5,5-difluoro-4-methylpiperidin-3-yl]methyl]methanesulfonamide);1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidine-3-carboxamide;N-[[1-[6-[6-(difluoromethyl)imidazo[1,2-b]pyridazin-3-yl]pyrimidin-4-yl]piperidin-3-yl]methyl]-1,1,1-trifluoromethanesulfonamide;6-(difluoromethyl)-3-[6-[2-(trifluoromethyl)piperidin-1-yl]pyrimidin-4-yl]imidazo[1,2-b]pyridazine |
| SMILES | CC1C(CNS(C)(=O)=O)CN(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)CC1(F)F.CC1C(CNS(C)(=O)=O)CN(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)CC1(F)F.FC(F)c1ccc2ncc(-c3cc(N4CCCCC4C(F)(F)F)ncn3)n2n1.NC(=O)C1CCCN(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)C1.O=S(=O)(NCC1CCCN(c2cc(-c3cnc4ccc(C(F)F)nn34)ncn2)C1)C(F)(F)F |
| InChI | InChI=1S/2C19H21F4N7O2S.C18H18F5N7O2S.C17H15F5N6.C17H17F2N7O/c2*1-11-12(6-27-33(2,31)32)8-29(9-19(11,22)23)17-5-14(25-10-26-17)15-7-24-16-4-3-13(18(20)21)28-30(15)16;19-17(20)12-3-4-15-24-8-14(30(15)28-12)13-6-16(26-10-25-13)29-5-1-2-11(9-29)7-27-33(31,32)18(21,22)23;18-16(19)10-4-5-14-23-8-12(28(14)26-10)11-7-15(25-9-24-11)27-6-2-1-3-13(27)17(20,21)22;18-16(19)11-3-4-14-21-7-13(26(14)24-11)12-6-15(23-9-22-12)25-5-1-2-10(8-25)17(20)27/h2*3-5,7,10-12,18,27H,6,8-9H2,1-2H3;3-4,6,8,10-11,17,27H,1-2,5,7,9H2;4-5,7-9,13,16H,1-3,6H2;3-4,6-7,9-10,16H,1-2,5,8H2,(H2,20,27) |
| InChIKey | NNGGSJNYOVKANX-UHFFFAOYSA-N |
| XLogP | 13.41 |
| TPSA | 477.65 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 37 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 154 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2238.12 |
| LogP ≤ 5 | 13.41 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 37 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159829288 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.